Want to see PBSV full AI Analyst Report?
Total Valuation
Pharma Bio Services has a market cap or net worth of $9.68M. The enterprise value is $11.26M.
Market Cap$9.68M
Enterprise Value$11.26M
Share Statistics
Pharma Bio Services has 22,901,691 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding22,901,691
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Pharma Bio Services’s return on equity (ROE) is >-0.01 and return on invested capital (ROIC) is -5.34%.
Return on Equity (ROE)>-0.01
Return on Assets (ROA)>-0.01
Return on Invested Capital (ROIC)-5.34%
Return on Capital Employed (ROCE)-0.05
Revenue Per Employee163.66K
Profits Per Employee-1.83K
Employee Count55
Asset Turnover0.66
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Pharma Bio Services is ―. Pharma Bio Services’s PEG ratio is 1.41.
PE Ratio―
PS Ratio1.38
PB Ratio1.04
Price to Fair Value1.04
Price to FCF-55.94
Price to Operating Cash Flow-0.03
PEG Ratio1.41
Income Statement
In the last 12 months, Pharma Bio Services had revenue of 9.00M and earned -100.46K in profits. Earnings per share was >-0.01.
Revenue9.00M
Gross Profit2.91M
Operating Income-637.66K
Pretax Income-94.26K
Net Income-100.46K
EBITDA134.81K
Earnings Per Share (EPS)>-0.01
Cash Flow
In the last 12 months, operating cash flow was -365.18M and capital expenditures -7.12K, giving a free cash flow of -365.19M billion.
Operating Cash Flow-365.18M
Free Cash Flow-365.19M
Free Cash Flow per Share-15.95
Dividends & Yields
Pharma Bio Services pays an annual dividend of $0.075, resulting in a dividend yield of ―
Dividend Per Share$0.075
Dividend Yield―
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.02
52-Week Price Change-19.31%
50-Day Moving Average0.54
200-Day Moving Average0.51
Relative Strength Index (RSI)29.56
Average Volume (3m)2.53K
Important Dates
Pharma Bio Services upcoming earnings date is Sep 16, 2026, TBA (Confirmed).
Last Earnings DateJun 15, 2026
Next Earnings DateSep 16, 2026
Ex-Dividend Date―
Financial Position
Pharma Bio Services as a current ratio of 7.70, with Debt / Equity ratio of 0.00%
Current Ratio7.70
Quick Ratio7.70
Debt to Market Cap0.00
Net Debt to EBITDA-24.85
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Pharma Bio Services has paid 6.20K in taxes.
Income Tax6.20K
Effective Tax Rate-0.07
Enterprise Valuation
Pharma Bio Services EV to EBITDA ratio is 67.06, with an EV/FCF ratio of -40.81.
EV to Sales1.00
EV to EBITDA67.06
EV to Free Cash Flow-40.81
EV to Operating Cash Flow-42.07
Balance Sheet
Pharma Bio Services has $8.47M in cash and marketable securities with $0.00 in debt, giving a net cash position of $8.47M billion.
Cash & Marketable Securities$8.47M
Total Debt$0.00
Net Cash$8.47M
Net Cash Per Share$0.37
Tangible Book Value Per Share$0.52
Margins
Gross margin is 32.35%, with operating margin of -7.08%, and net profit margin of -1.12%.
Gross Margin32.35%
Operating Margin-7.08%
Pretax Margin-1.05%
Net Profit Margin-1.12%
EBITDA Margin1.50%
EBIT Margin-1.05%
Analyst Forecast
The average price target for Pharma Bio Services is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-5.49%
EPS Growth Forecast―